Figure 2.
Correlation between GHRL mRNA expression level and clinicopathological parameters of GC through the UALCAN database. (A) Sample type (normal/primary tumor). (B) (H) pylori status. (C) Cancer stage (stage 1–4). N, normal; P, primary tumor; S1, stage 1; S2, stage 2; S3, stage 3; S4, stage 4; STAD, stomach adenocarcinoma. Red mark represents a statistically significant difference between groups.